| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |